SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing a significant pullback, driven by renewed concerns over potential tariff escalations with China, sparking volatility. The community is actively debating whether this dip presents a buying opportunity or signals a deeper correction, with some anticipating a "V"-shaped recovery while others brace for further downside. This is happening amid discussions around government shutdowns, delayed CPI data, and the Federal Reserve's potential policy response.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals is trending due to a recently announced private placement of up to $104.5 million, exciting investors with the potential for growth. Community chatter highlights the stock's low float and speculation about a short squeeze, with some drawing comparisons to similar situations like $SPRB. The overall sentiment suggests anticipation for significant upward movement, with some traders setting ambitious price targets.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing volatility amid concerns about potential tariff increases on Chinese goods, sparked by comments from a former US president. Community sentiment is mixed, with some traders anticipating a deeper correction and others expecting a quick rebound, while some are mentioning potential market manipulation. Traders are closely monitoring key technical levels and the VIX, with many citing the potential for a "V-shaped" recovery.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 2x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is trending as traders assess potential market volatility amidst economic uncertainty and geopolitical tensions, with some anticipating a significant spike. Community members are actively discussing potential catalysts such as government shutdowns and are weighing the impact of various economic indicators. The conversation also highlights UVXY's complex relationship with the broader market, particularly its role as a hedge against potential downturns.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP is trending amidst volatility, with community discussions focusing on its potential as a key player in the rare earth market following government support and strategic partnerships. A possible Trump administration stake in critical metals and tighter export controls in China on rare earth are being closely watched. Community members are weighing potential impact on the stock, alongside technical analyses and potential breakout patterns.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the crypto community discusses its recent price movement, with some anticipating a breakout past key resistance levels. Community members are pointing to potential ETF approvals and its role as 'digital silver' as possible catalysts. Traders are actively watching technical indicators and discussing potential price targets amidst broader market fluctuations.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

SG Blocks Inc

SGBX is trending due to a mix of factors, including potential catalysts related to feasibility expansion, UK pilot updates, and regulatory announcements. The community is actively discussing float mechanics, short squeeze potential given the low share count, and the impact of a recent offering on the stock's price. Technical analysis and identification of potential breakout patterns are also contributing to the heightened interest in SGBX.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is experiencing volatility, driven by market reactions to broader economic concerns, including potential tariffs. The community is actively discussing dip-buying opportunities and potential manipulation, with some expressing frustration over ETH's performance relative to other assets. Despite the current uncertainty, some anticipate a future breakout and continue to emphasize the long-term potential of ETH and its underlying technology.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending due to increased investor interest in antimony as a critical mineral, particularly following news of potential government support and contracts, with community members discussing price targets and the company's growth potential. The stock is seen as a key player in North American antimony production amid global supply chain concerns and geopolitical factors. Some traders are concerned about short-term volatility and profit-taking, while long-term investors remain bullish.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is trending amid speculation of potential government investment, fueled by the CEO's recent confirmation of talks with the White House. The community is discussing the implications of USAR's mine-to-magnet strategy and its role in reducing reliance on foreign rare earth supplies. Broader market context includes increased interest in domestic rare earth production following recent trade tensions and government support for critical mineral companies.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IceCure Medical to Attend the 2025 Maxim Growth Summit

IceCure Medical to Attend the 2025 Maxim Growth Summit IceCure Medical to Attend the 2025 Maxim Growth Summit PR Newswire CAESAREA, Israel, Oct. 9, 2025 IceCure recently achieved a significant...

ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment

IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.

Shares of IceCure Medical (ICCM) went as high as $1.4 on Friday afternoon before paring back gains after the U.S. Food and Drug Administration granted marketing authorization for ProSense, a minimally invasive cryoablation treatment.ProSense is for patients aged 70 and over with early-stage low-risk breast cancer and treated with adjuvant endocrine therapy. It is the first and only medical device to receive FDA marketing authorization for the local treatment of breast cancer, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.icecure-medical.com/news-events/press-releases/detail/191/icecure-medicals-prosense-cryoablation-granted-fda-marketing-authorization-for-treatment-of-low-risk-breast-cancer-in-women-aged-70-and-above-significant-development-in-giving-women-with-breast-cancer-minimally-invasive-care">stated</a>.During the ProSense cryoablation procedure, a doctor injects local anesthesia and uses ultrasound imaging to guide a small cryoprobe, a thin hollow needle, into the breast tumor. Once the cryoprobe is placed, liquid nitrogen creates extremely cold temperatures, which destroy the breast tumor by creating an ice ball around the targeted tissue.The approval of the treatment was based on data, including a multi-centre clinical trial with 194 patients. Only 3.1% of patients with hormone receptor-positive and HER2-breast cancer treated locally with cryoablation and endocrine therapy experienced local recurrence of breast cancer within five years after treatment in the study, IceCure said.The company, however, stated that the FDA has requested it conduct a post-market surveillance study to generate additional data. The post-market study is expected to include approximately 400 patients, IceCure said.IceCure lists several benefits to its treatment, including maintenance of breast shape, a short, outpatient procedure, and reduced recovery time. The majority of adverse events identified in studies were swelling, bruising, hematoma, skin burn, and postoperative pain, which were mild in severity, it added.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ICCM">ICCM stock</a> soared from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:576/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_03_at_2_00_01_PM_png_a1d54603d1.webp" alt="ICCM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Oct. 03, 2025 | Source: Stocktwits" width="576" height="61"><figcaption>ICCM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Oct. 03, 2025 | Source: Stocktwits</figcaption></figure>ICCM stock is down 4% this year but up by about 74% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rocket-pharma-stock-gets-price-target-cut-after-withdrawing-fda-application-for-rare-bone-marrow-disorder-gene-therapy/chCuqQ5R3Qm">Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

IceCure Medical’s Treatment For Low-Risk Breast Cancer In Women Aged 70 And Over Receives FDA Approval

The company stated that the FDA has requested it conduct a post-market surveillance study to generate additional data.

Equity

IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates

IceCure Medical (ICCM) delivered earnings and revenue surprises of +200.00% and -34.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates

Viatris (VTRS) delivered earnings and revenue surprises of +10.71% and +2.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates

Labcorp (LH) delivered earnings and revenue surprises of +5.07% and +1.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Misses Revenue Estimates

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation...

IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision

IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates...

IceCure Files for Regulatory Approval of ProSense Cryoablation System in China

IceCure Files for Regulatory Approval of ProSense Cryoablation System in China IceCure Files for Regulatory Approval of ProSense Cryoablation System in China PR Newswire CAESAREA, Israel, Jan. 27...

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Icecure Medical Ltd

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.05	--	--	N/A
Q2 '25	-$0.06	-$0.06	--	EXPECTED
Q1 '25	-$0.08	-$0.06	26.41%	BEAT
Q4 '24	-$0.08	--	--	N/A
Q3 '24	-$0.08	-$0.08	--	EXPECTED

ICCM
Icecure Medical Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ICCM News

ICCMIcecure Medical Ltd